The Food and Drug Administration has warned Novo Nordisk that a television advertisement promoting its newly launched Wegovy pill for obesity contains “false or misleading” claims, saying the spot misbrands the drug and violates federal law, CNBC reported Monday.[#item_full_content]
Eli Lilly in Advanced Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Aprile 19, 2026
Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, The Wall Street Journal reported on Sunday.[#item_full_content]
